The European Association for the Study of Diabetes Annual Meeting Illuminates Next-Generation Obesity Treatments and Intensifying Pharmaceutical Race
admin Milan, Italy – The annual meeting of the European Association for the Study of Diabetes...
admin
Pharmaceutical Industry Reshapes Leadership and Bolsters Pipelines with Key Approvals and Strategic Acquisitions
The biopharmaceutical sector is experiencing a period of significant strategic realignment, marked by a high-profile...
Gold Ribbon Hero: Macon
Upon arrival at the emergency department, Macon underwent a battery of intensive diagnostic tests to...
Running for Research Team CCRF Athletes Champion Childhood Cancer Awareness at Medtronic Twin Cities Marathon
The Medtronic Twin Cities Marathon weekend, a cornerstone of the Minnesota athletic calendar, serves as...
Osama Alsaleh Joins CureSearch Board of Directors to Drive Innovation in Pediatric Cancer Research and Venture Capital Partnerships
CureSearch for Children’s Cancer, a leading national non-profit foundation dedicated to accelerating the development of...
Cancer Research Institute Commits Record $34.4 Million to Propel Cancer Immunotherapy Research Amidst Global Funding Uncertainty
In a landscape increasingly defined by fiscal prudence and scientific funding instability, the Cancer Research...
Victoria Ann Michelis Fund Fuels Pioneering Research in Ovarian Cancer and Supports Underdogs
The indelible spirit of Victoria “Vicky” Ann Michelis, a woman who championed the underdog and...
Roche’s Fenebrutinib Faces Regulatory Scrutiny Despite Landmark FDA Application Acceptance for Multiple Sclerosis.
The U.S. Food and Drug Administration (FDA) has accepted Roche’s application for fenebrutinib, a Bruton’s...
Nine-Year-Old Lauren Kate Faces Dual Challenge of B-Cell Acute Lymphoblastic Leukemia and Down Syndrome
The diagnostic journey for Lauren Kate, a nine-year-old girl previously navigating the complexities of Down...
Bristol Myers trial revisions shake confidence in new class of fibrosis drugs
Bristol Myers Squibb (BMS) has confirmed that its investigational drug, admilparant, an LPA1 receptor inhibitor,...
